logo
Rare 19th-century condom with erotic etching goes on display at Dutch museum

Rare 19th-century condom with erotic etching goes on display at Dutch museum

CNN2 days ago

CNN —
A rare 19th-century condom decorated with an erotic etching featuring a nun and three clergymen is going on display at a museum in the Netherlands.
Believed to be made from a sheep's appendix, the prophylactic dates back to 1830 and is likely a souvenir from a brothel, according to a statement from the Rijksmuseum in Amsterdam on Tuesday.
Joyce Zelen, curator of prints at the museum, told CNN that condoms would have been sold under the counter at the time.
This example is in 'mint condition,' she said, with UV testing revealing that it hasn't been used.
This fact, as well as the print and the extended length of the condom, which is 20 centimeters (7.9 inches) long, suggest that this was 'a luxury brothel souvenir,' added Zelen.
'It makes it more of an object to laugh about with your friends than an actual object to use,' she said.
In the etching, the nun can be seen seated with her legs open while the three clergymen hold up their robes, revealing their erect penises.
'The inscription Voilà mon choix, meaning 'This is my choice,' makes the print a parody of both celibacy and the Judgement of Paris from Greek mythology,' said the museum.
Zelen explained that the printmaker would have laid the appendix of a sheep or goat out flat and used a copper plate with the inked etching on it to print the design onto it.
While this kind of condom was not likely to have been used, those designed to protect the wearer would have been made with similar materials, said Zelen.
They would have provided minimal protection from unwanted pregnancies and sexual transmitted infections such as syphilis, which was a significant public health problem in 19th century Europe, she added.
The Rijksmuseum acquired the condom at auction six months ago and it is the first example of a print on a condom to form part of the museum's collection.
It will be on display in the museum's Print Room until the end of November as part of an exhibit on 19th century prostitution and sexuality.
In recent years the Rijksmuseum has hit the headlines for putting together the largest ever exhibition of paintings by Dutch painter Johannes Vermeer, as well as for repatriating colonial artifacts to Sri Lanka following provenance research that started in 2017.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NewAmsterdam Pharma to Host R&D Day on June 11, 2025
NewAmsterdam Pharma to Host R&D Day on June 11, 2025

Yahoo

time4 hours ago

  • Yahoo

NewAmsterdam Pharma to Host R&D Day on June 11, 2025

NAARDEN, The Netherlands and MIAMI, June 05, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or 'NewAmsterdam' or the 'Company'), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease ('CVD') with elevated low-density lipoprotein cholesterol ('LDL-C'), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that it will host an R&D Day event for analysts and investors on June 11, 2025 beginning at 9:00 a.m. ET in New York City. Please join members of our management team, including: Michael Davidson, M.D., Chief Executive Officer, John Kastelein, M.D., Ph.D., FESC, Founder and Chief Scientific Officer, BJ Jones, Chief Commercial Officer, Ian Somaiya, Chief Financial Officer, and Matthew Philippe, Executive Vice President. A live webcast of the R&D event will be available and those who intend to join virtually can pre-register for the webcast through the link here. The live webcast and supporting presentation materials will be available on the Events section of the Investor Relations page of the NewAmsterdam website at at the time of the live event. An archived replay will be available on the NewAmsterdam website. Please note advanced registration is required for in-person attendance. About ObicetrapibObicetrapib is a novel, oral, low-dose CETP inhibitor that NewAmsterdam is developing to overcome the limitations of current LDL-lowering treatments. In each of the Company's Phase 2 trials, ROSE2, TULIP, ROSE, and OCEAN, as well as the Company's Phase 3 BROOKLYN, BROADWAY and TANDEM trials, evaluating obicetrapib as monotherapy or combination therapy, the Company observed statistically significant LDL-lowering combined with a side effect profile similar to that of placebo. The Company commenced the Phase 3 PREVAIL CVOT in March 2022, which is designed to assess the potential of obicetrapib to reduce occurrences of MACE. The Company completed enrollment of PREVAIL in April 2024 and randomized over 9,500 patients. Commercialization rights of obicetrapib in Europe, either as a monotherapy or as part of a fixed-dose combination with ezetimibe, have been exclusively granted to the Menarini Group, an Italy-based, leading international pharmaceutical and diagnostics company. About NewAmsterdamNewAmsterdam Pharma (Nasdaq: NAMS) is a late-stage, clinical biopharmaceutical company whose mission is to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. We seek to fill a significant unmet need for a safe, well-tolerated and convenient LDL-lowering therapy. In multiple Phase 3 trials, NewAmsterdam is investigating obicetrapib, an oral, low-dose and once-daily CETP inhibitor, alone or as a fixed-dose combination with ezetimibe, as LDL-C lowering therapies to be used as an adjunct to statin therapy for patients at risk of CVD with elevated LDL-C, for whom existing therapies are not sufficiently effective or well tolerated. Company ContactMatthew PhilippeP: Media ContactSpectrum Science on behalf of NewAmsterdamJaryd LeadyP: 1-856-803-7855jleady@ Investor ContactPrecision AQ on behalf of NewAmsterdamAustin MurtaghP:

The Dutch queen unveils a bell made from Russian weapons to show solidarity with Ukraine
The Dutch queen unveils a bell made from Russian weapons to show solidarity with Ukraine

Associated Press

time6 hours ago

  • Associated Press

The Dutch queen unveils a bell made from Russian weapons to show solidarity with Ukraine

PRAGUE (AP) — Queen Maxima of the Netherlands handed over a bell made partly from Russian weapons to a church in the Czech Republic on Thursday in a sign of solidarity with Ukraine. Known as the Bell of Freedom, it was manufactured by the Dutch Royal Eijsbouts bell foundry that used fragments of artillery shells and other weapons fired by Russia against Ukraine. 'This bell has a lot of symbolism in it and it's a very special project for us,' the owner of the bell foundry, Joost Eijsbouts, told the Czech public radio. 'To use material designed for violence and turn it into something peaceful is a good idea.' The bell will be installed in the tower of the Church of the Holy Saviour in Prague, in place of one of the original bells that were seized by the Austro-Hungarian army and turned into weapons during World War I. The Czech Republic and the Netherlands support Ukraine in its fight against Russian troops. The ceremony at the church, attended by Czech President Petr Pavel and his wife Eva, was meant to be one of the highlights of the Dutch royal couple's stay in Prague. But King Willem-Alexander had to cut short the trip and returned home late Wednesday due to the collapse of the Dutch government.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store